93 Enhanced antiviral efficacy for valopicitabine (NM283) plus peg-interferon in hepatitis C patients with HCV genotype-1 infection: Results of a phase IIa multicenter trial
- 30 April 2005
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 42, 39-40
- https://doi.org/10.1016/s0168-8278(05)81505-3
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: